Evidence map›Paper›PMID 32654398›Full record

ReviewJournal of diabetes investigation2021

Role of O-linked N-acetylglucosamine in the homeostasis of metabolic organs, and its potential links with diabetes and its complications.

Katsutaro Morino, Hiroshi Maegawa

Open access · goldAbstract readReview
In one paragraph

Review in Journal of diabetes investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Review
  3. Immunohistochemical Study onActa histochemica et cytochemica · 2025
    Review
  4. O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.International journal of molecular sciences · 2024
    Review
  5. Heliyon · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Cells · 2022
    Review
  10. Review
  11. Review
  12. The Dysregulation of OGT/OGA Cycle Mediates Tau and APP Neuropathology in Down Syndrome.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Katsutaro MorinoDivision of Diabetology, Endocrinology, and Nephrology, Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.ORCID https://orcid.org/0000-0003-2420-3817
Hiroshi MaegawaDivision of Diabetology, Endocrinology, and Nephrology, Department of Medicine, Shiga University of Medical Science, Otsu, Shiga, Japan.ORCID https://orcid.org/0000-0002-4611-8149
Shiga University of Medical Science · JP

Funding

JSPS KAKENHI JP15K09383JSPS KAKENHI JP16K09743JSPS KAKENHI JP16K09744JSPS KAKENHI JP18H02862JSPS KAKENHI JP19K08998JSPS KAKENHI JP24591350JSPS KAKENHI JP60816776JSPS KAKENHI JP90792028
6 · The paper itself

Abstract

Recent studies using genetically manipulated mouse models have shown the pivotal role of O-linked N-acetylglucosamine modification (O-GlcNAcylation) in the metabolism of multiple organs. The molecular mechanism involves the sensing of glucose flux by the hexosamine biosynthesis pathway, which leads to the adjustment of cellular metabolism to protect against changes in the environment of each organ through O-GlcNAcylation. More recently, not only glucose, but also fluxes of amino acids and fatty acids have been reported to induce O-GlcNAcylation, affecting multiple cellular processes. In this review, we discuss how O-GlcNAcylation maintains homeostasis in organs that are affected by diabetes mellitus: skeletal muscle, adipose tissue, liver and pancreatic β-cells. Furthermore, we discuss the importance of O-GlcNAcylation in the pathogenesis of diabetic complications. By elucidating the molecular mechanisms whereby cellular homeostasis is maintained, despite changes in metabolic flux, these studies might provide new targets for the treatment and prevention of diabetes and its complications.

Indexed as

HomeostasisProtein Processing, Post-TranslationalAcetylglucosamineAnimalsDiabetes ComplicationsDiabetes MellitusGlucoseHumansMultiple Organ FailureAcetylglucosamineGlucoseDiabetic complicationO-linked N-acetylglucosamine modificationPost-translational modification

Identifiers

PMID32654398
PMCPMC7858115
OpenAlexW3042123847

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.